Evidence map›Paper›PMID 23569333›Full record

ReviewWorld journal of gastroenterology2013

Role of T cell death in maintaining immune tolerance during persistent viral hepatitis.

Juan Ramón Larrubia, Megha Uttam Lokhande, Silvia García-Garzón, Joaquín Miquel, Dolores Subirá, Eduardo Sanz-de-Villalobos

Open access · bronzeAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Genome-Wide CRISPR Screen Identifies Host Factors Required byFrontiers in cellular and infection microbiology · 2019
    Article
  3. A Rare Case of Pembrolizumab-Induced Reactivation of Hepatitis B.Case reports in oncological medicine · 2018
    Article
  4. Review
  5. Adaptive immune response during hepatitis C virus infection.World journal of gastroenterology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Juan Ramón LarrubiaTranslational Hepatology Unit, Guadalajara University Hospital, University of Alcalá, 19002 Guadalajara, Spain.
Megha Uttam Lokhande
Silvia García-Garzón
Joaquín Miquel
Dolores Subirá
Eduardo Sanz-de-Villalobos
Universidad de Alcalá · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Virus-specific T cells play an important role in the resolution of hepatic infection. However, during chronic hepatitis infection these cells lack their effector functions and fail to control the virus. Hepatitis B virus and hepatitis C virus have developed several mechanisms to generate immune tolerance. One of these strategies is the depletion of virus-specific T cells by apoptosis. The immunotolerogenic liver has unique property to retain and activate naïve T cell to avoid the over reactivation of immune response against antigens which is exploited by hepatotropic viruses to persist. The deletion of the virus-specific T cells occurs by intrinsic (passive) apoptotic mechanism. The pro-apoptotic molecule Bcl-2 interacting mediator (Bim) has attracted increasing attention as a pivotal involvement in apoptosis, as a regulator of tissue homeostasis and an enhancer for the viral persistence. Here, we reviewed our current knowledge on the evidence showing critical role of Bim in viral-specific T cell death by apoptotic pathways and helps in the immune tolerance.

Indexed as

Immune ToleranceApoptosisApoptosis Regulatory ProteinsBcl-2-Like Protein 11Cell DeathHepatitis, Viral, HumanHumansLiverMembrane ProteinsProto-Oncogene ProteinsT-LymphocytesApoptosis Regulatory ProteinsBCL2L11 protein, humanBcl-2-Like Protein 11Membrane ProteinsProto-Oncogene ProteinsApoptosisApoptotic pathwaysBcl-2 interacting mediatorHepatitis C virus immune toleranceLiver toleranceSpecific cytotoxic T lymphocytesT cell deathViral hepatitis

Identifiers

PMID23569333
PMCPMC3613103
OpenAlexW2116142164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.